rdf:type |
|
lifeskim:mentions |
umls-concept:C0005889,
umls-concept:C0017262,
umls-concept:C0043210,
umls-concept:C0185117,
umls-concept:C0205092,
umls-concept:C0238767,
umls-concept:C0242957,
umls-concept:C0443199,
umls-concept:C0853879,
umls-concept:C1512083,
umls-concept:C1517050,
umls-concept:C1521806,
umls-concept:C2911684
|
pubmed:issue |
2
|
pubmed:dateCreated |
2003-2-10
|
pubmed:abstractText |
Overexpression of HER-2/neu is associated with aggressive diseaseand perhaps with increased risk of breast cancer when presentin benign breast tissue. Breast ductal fluid can be obtained from women by simple nipple aspiration and may be useful for analyzing the microenvironment of the breast.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
1078-0432
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
9
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
601-5
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:12576424-Adult,
pubmed-meshheading:12576424-Aged,
pubmed-meshheading:12576424-Bodily Secretions,
pubmed-meshheading:12576424-Breast,
pubmed-meshheading:12576424-Breast Neoplasms,
pubmed-meshheading:12576424-Carcinoma,
pubmed-meshheading:12576424-Continental Population Groups,
pubmed-meshheading:12576424-Female,
pubmed-meshheading:12576424-Humans,
pubmed-meshheading:12576424-Middle Aged,
pubmed-meshheading:12576424-Neoplasm Invasiveness,
pubmed-meshheading:12576424-Neoplasm Staging,
pubmed-meshheading:12576424-Nipples,
pubmed-meshheading:12576424-Receptor, erbB-2,
pubmed-meshheading:12576424-Reference Values,
pubmed-meshheading:12576424-Texas,
pubmed-meshheading:12576424-Tumor Markers, Biological
|
pubmed:year |
2003
|
pubmed:articleTitle |
High and differential expression of HER-2/neu extracellular domain in bilateral ductal fluids from women with unilateral invasive breast cancer.
|
pubmed:affiliation |
Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|